The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Workers are ready to fight against real pay cuts, chronic staffing shortages and unsafe conditions, but their efforts are ...

Pathology workers at Australian Clinical Laboratories (ACL ... s enterprise agreement offer that cuts real wages. COVID-19 testing site in Melbourne [Photo: X/@JoanWil85024201] The company ...

Mayo Clinic launched a new prion test, RT-QuIC Prion, CSF, which can distinguish prion disease from other causes of rapidly ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...

In response to this season’s high flu activity and the ongoing avian flu outbreaks, the Centers for Disease Control and Prevention (CDC) has advised clinicians and laboratories to conduct subtype ...

Cenmed expands kitting services, offering custom lab, pathology, and clinical trial kits to streamline healthcare and research workflows. #LabKits ...

Under the agreement, Metropolis Clinical Pathology will acquire all laboratories and collection centers of Scientific Pathology in Agra and surrounding towns through a slump sale transaction.